Axes of biological variation in diffuse large B cell lymphoma
Authors:
- Julius C. EnssleJEJulius C. Enssle
Open Access
- 15 January 2026
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 44 (3) , 567-585.e12
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- Center for Cancer Research
- Deutsche Krebshilfe (70116591)
- University of North Carolina
- National Institutes of Health
- Deutsche Forschungsgemeinschaft (SFB1530)
- Deutsche Forschungsgemeinschaft (EN 1338/1-1)
- Deutsche Forschungsgemeinschaft (455784452)
This publication has 115 references indexed in Scilit:
- Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomasCancer Cell, 2024
- Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCLCancer Cell, 2021
- The landscape of tumor cell states and ecosystems in diffuse large B cell lymphomaCancer Cell, 2021
- A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic ImplicationsCancer Cell, 2020
- Comprehensive Integration of Single-Cell DataCell, 2019
- MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell LymphomagenesisCancer Cell, 2018
- Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS LymphomaCancer Cell, 2017
- Determination and Inference of Eukaryotic Transcription Factor Sequence SpecificityCell, 2014
- B‐cell‐intrinsic STAT6 signaling controls germinal center formationEuropean Journal of Immunology, 2014
- Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell LymphomaCancer Cell, 2012